Tetsuji Nagasawa

Title: Tetsuji Nagasawa: Innovator in Viral Production Methods

Introduction

Tetsuji Nagasawa is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of virology through his innovative methods for producing viruses using cultured cells. His work has implications for both research and therapeutic applications.

Latest Patents

Nagasawa holds a patent for "Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells." This patent describes a novel cell that is well-suited for the mass production of the Hemagglutinating Virus of Japan (HVJ). The human cell, derived from a transformed human kidney cell line, exhibits a doubling time of no more than 40 hours in suspension culture within a serum-free medium. Additionally, the cell possesses freeze-recovery properties and can achieve a maximum density of viable cells of at least 10 cells/mL, allowing for effective growth of HVJ.

Career Highlights

Nagasawa's career is marked by his dedication to advancing viral production techniques. His innovative methods have the potential to enhance the efficiency of virus production, which is crucial for both research and clinical applications. His work exemplifies the intersection of biotechnology and virology.

Collaborations

Throughout his career, Nagasawa has collaborated with notable colleagues, including Takahiro Yano and Akiko Temma. These collaborations have likely contributed to the development and refinement of his innovative methods.

Conclusion

Tetsuji Nagasawa's contributions to the field of virology through his patented methods for virus production highlight his role as an influential inventor. His work continues to pave the way for advancements in viral research and therapeutic applications.